Neonatal/Perinatology

Latest News


CME Content


A meta-analysis of 12 studies of the risk of death after a brief resolved unexplained event (BRUE) found that such an event does not increase an infant’s risk of dying during his or her first year. The American Academy of Pediatrics (AAP) introduced BRUE, a sudden alteration in an infant’s breathing, color, tone, or responsiveness, as a replacement for “apparent life-threatening event” (ALTE) in a 2016 clinical practice guideline.

Previous studies conducted in animals and in humans have suggested that DHA might be helpful in reducing the risk of bronchopulmonary dysplasia (BPD). However, the results of a very recent study demonstrated that the supplementation of an emulsion containing DHA did not reduce the risk of preterm infants developing BPD compared with infants who received a control emulsion without DHA.

A large retrospective study of how infants with fever without a cause are evaluated found that physicians are selective in deciding which of these babies will have blood, urine, or cerebral spinal fluid cultures.

Superficial, relatively thin infantile hemangiomas (IHs) responded to several months of treatment with topical timolol maleate in a recent trial, suggesting that this treatment is an alternative to oral propranolol for selected IHs.